Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions

NCT00837915 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended-Release Tablets

Sponsor

Ranbaxy Laboratories Limited